-
2015-2024 Pricing Advantage of First-in-Indication Non-Oncology Orphan Products Versus Late Entrants and Recent Trends
Mar 10, 2025, 14:00 PM -
Patient Voice in Rare Disease Health Technology Assessments: Recent Trends in the Use of Qualitative Research in Reimbursement Submissions to Canada's Drug Agency
Mar 10, 2025, 14:00 PM -
Development and Validation of a Claims-Based Approach to Identify Patients with Metastatic HR+ HER2- Breast Cancer
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness Analysis of Momelotinib for the Treatment of Adult Patients With Myelofibrosis and Anemia in Canada
Mar 10, 2025, 14:00 PM -
Are Workforce Productivity Measures Useful for Formulary Management Decision-Making?
Mar 10, 2025, 14:00 PM -
Disparities in Access to COPD Medications in Brazil - Impact of Geography and Socioeconomic Factors on Patient Travel Distances
Mar 10, 2025, 14:00 PM -
Development of a Conceptual Model of the Patient Experience with Idiopathic Hypersomnia: Patient Interviews from a Clinical Trial (NCT05156047)
Mar 10, 2025, 14:00 PM -
Analysis of the Human Development Index by Innovation In Health, Through the Incorporation of New Technologies In Oncology: Preliminary Data in LMIC/LATAM/Brazil
Mar 10, 2025, 14:00 PM -
Early Breast Cancer in the US and Germany: A Comparison of Real-world Screening and Treatment
Mar 10, 2025, 14:00 PM -
Diffusion and Launch Sequencing of Cell and Gene Therapies across the USA, Europe, Canada and Australia
Mar 10, 2025, 14:00 PM -
Application of Generative Artificial Intelligence for Extracting Structured Data from Unstructured Bladder Cancer Pathology Reports
Mar 10, 2025, 14:00 PM -
Prescription Cost Dynamics in Chronic Disease Management: The Role of PMBJP-Scheme in Enhancing Affordability in India
Mar 10, 2025, 14:00 PM -
Impact of NGS Testing Timing on Real-World Treatment Patterns and Clinical Outcomes in Colorectal Cancer: A Retrospective Observational Study
Mar 10, 2025, 14:00 PM -
Trend of Cervical Cancer Mortality in Colombia From 1998 to 2022
Mar 10, 2025, 14:00 PM -
The Emerging Potential of International Reference Pricing (IRP) in the US: An Analysis of Trends, Challenges, Opportunities and learnings from Europe
Mar 10, 2025, 14:00 PM -
Impact of Primary Care Subsidies on Healthcare Utilization: Evidence From Singapore's Merdeka Generation Package
Mar 10, 2025, 14:00 PM -
Developing a Checklist for Patient Engagement in Rare Disease Value Research
Mar 10, 2025, 14:00 PM -
Cost-Utility Analysis of Faricimab Versus Aflibercept in Treating Neovascular Age-Related Macular Degeneration (nAMD) in the United States
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness of Pegfilgrastim Versus 5-day Filgrastim in Early Breast Cancer Patients Undergoing Neoadjuvant and Adjuvant Chemotherapy: A Trial-Based Economic Evaluation
Mar 10, 2025, 14:00 PM -
Role of Relative Dose Intensity in Health Economic Evaluations: A Review of National Institute for Health and Care Excellence Technology Appraisals of Treatments in Solid Tumors
Mar 10, 2025, 14:00 PM
